Education Research Current About VU Amsterdam NL
Login as
Prospective student Student Employee
Bachelor Master VU for Professionals
Exchange programme VU Amsterdam Summer School Honours programme VU-NT2 Semester in Amsterdam
PhD at VU Amsterdam Research highlights Prizes and distinctions
Research institutes Our scientists Research Impact Support Portal Creating impact
News Events calendar Woman at the top
Israël and Palestinian regions Culture on campus
Practical matters Mission and core values Entrepreneurship on VU Campus
Organisation Partnerships Alumni University Library Working at VU Amsterdam
Sorry! De informatie die je zoekt, is enkel beschikbaar in het Engels.
This programme is saved in My Study Choice.
Something went wrong with processing the request.
Something went wrong with processing the request.

EMPOWER GR

The number of older adults is increasing, and thereby also the demand for geriatric rehabilitation after an acute hospitalization and accompanied functional decline. Sarcopenia, the age-related low muscle strength and muscle mass, is present in more than 50% of geriatric rehabilitation patients and associated with mortality and worse functional recovery.

Geriatric rehabilitation primarily aims to achieve functional goals (walking, dressing, toileting, transferring etc.) to enable patients to return home, but we believe it offers a good window of opportunity to combat sarcopenia  with resistance exercise training (RET) and protein supplementation. However, sarcopenia awareness, feasibility to diagnose and treat sarcopenia and efficacy of treatment in geriatric rehabilitation patients remain to be established. With this aim, EMPOWER-GR (Enhancing Muscle POWER in Geriatric Rehabilitation) started in 2020.

Main objectives

EMPOWER-GR encompasses four pillars:

1) an observational study of 200 geriatric rehabilitation inpatients determining sarcopenia prevalence, functional and nutritional status at admission

2) a survey among these 200 patients and 500 healthcare professionals and semi-structured interviews in 30 patients and 15 carers determining sarcopenia awareness and barriers/enablers regarding diagnostics and treatment

3) a feasibility randomized controlled trial (RCT) in 80 patients with sarcopenia admitted to geriatric rehabilitation. The active group receives three RET sessions per week and protein supplementation (oral nutritional supplement) twice daily in combination with usual care for 13 weeks. The control group (n = 40) receives usual care. Primary outcomes are feasibility (adherence to the intervention, drop-out rate, overall feasibility) and change in muscle mass

4) knowledge sharing on sarcopenia diagnosis and treatment

Evidence from EMPOWER-GR is expected to encourage and facilitate the implementation and optimization of diagnostic and treatment strategies for sarcopenia in geriatric rehabilitation.

Consortium

EMPOWER-GR is a consortium of university (VU, Vrije Universiteit Amsterdam), academic hospital (Amsterdam UMC), geriatric rehabilitation care provider (Cordaan) and industry (Danone Nutricia Research) partners in the Netherlands.

The collaboration project is co-funded by the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health, and Top Sector Agri & Food to stimulate public-private partnerships, and includes a contribution from Danone Nutricia Research.

Quick links

Homepage Culture on campus VU Sports Centre Dashboard

Study

Academic calendar Study guide Timetable Canvas

Featured

VUfonds VU Magazine Ad Valvas Digital accessibility

About VU

Contact us Working at VU Amsterdam Faculties Divisions
Privacy Disclaimer Veiligheid Webcolofon Cookies Webarchief

Copyright © 2025 - Vrije Universiteit Amsterdam